VLON
NASDAQVallon Pharmaceuticals Inc.
Vallon Pharmaceuticals Inc. (VLON) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. There were no new wire items for VLON in the last 30 days. The most recent was published Feb 2, 2024.
Latest news
25 items- SECSEC Form 424B3 filed by Vallon Pharmaceuticals Inc.424B3 - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form 424B4 filed by Vallon Pharmaceuticals Inc.424B4 - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form EFFECT filed by Vallon Pharmaceuticals Inc.EFFECT - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)S-1/A - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)S-1/A - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form 424B3 filed by Vallon Pharmaceuticals Inc.424B3 - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form 424B3 filed by Vallon Pharmaceuticals Inc.424B3 - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form DEFA14A filed by Vallon Pharmaceuticals Inc.DEFA14A - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form 424B3 filed by Vallon Pharmaceuticals Inc.424B3 - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form DEF 14A filed by Vallon Pharmaceuticals Inc.DEF 14A - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form S-1 filed by Vallon Pharmaceuticals Inc.S-1 - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form PRE 14A filed by Vallon Pharmaceuticals Inc.PRE 14A - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form EFFECT filed by Vallon Pharmaceuticals Inc.EFFECT - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form 424B3 filed by Vallon Pharmaceuticals Inc.424B3 - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECSEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)S-1/A - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GRI BIO, Inc. (0001824293) (Filer)
- SECVallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - GRI BIO, Inc. (0001824293) (Filer)
VLON FAQ
8 questionsWhat does Vallon Pharmaceuticals Inc. do?
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.What is the latest news on VLON?
Quantisnow has not tracked any new filings, ratings or press releases for VLON in the last 30 days. The most recent wire item was published on February 2, 2024.Where does VLON stock trade?
Vallon Pharmaceuticals Inc. (VLON) is listed on NASDAQ.What sector and industry is VLON in?
Vallon Pharmaceuticals Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Vallon Pharmaceuticals Inc. go public?
Vallon Pharmaceuticals Inc. (VLON) completed its IPO in 2021.What are analysts saying about VLON?
Vallon Pharmaceuticals Inc. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $12.00 price target on 2021-11-22. Recent price targets cluster around $12.00.What companies are similar to VLON?
Notable peers in the same industry include SMFL (Smart for Life Inc.), SQZ (SQZ Biotechnologies Company), MNMD (Mind Medicine (MindMed) Inc.), GRPH (Graphite Bio Inc.), SISI (Shineco Inc.). Compare VLON side-by-side with any of them on Quantisnow.How can I track VLON on Quantisnow?
Quantisnow aggregates Vallon Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VLON to receive live email and push alerts on every new disclosure.